ESMO 2025

ESMO 2025 Poster

EANM 2025 Abstracts

Adaptive Design and Dose Optimization – TheraPb Phase I/II Study

Radiation Safety with ²¹²Pb-ADVC001

²¹²Pb imaging by pair production PET confirms localization of alpha emissions in tumor

Deep Longitudinal Immunophenotyping in patients treated with ²¹²Pb-ADVC001

Featured Article

Alpha Therapy and Combination Strategies to Overcome Resistance and Enhance Clinical Outcomes in Prostate Cancer